Can AI stop ALS, Parkinson's? This startup has 32 million new reasons to try
DFJ, a WuXi AppTech venture fund and others are sold on the San Francisco startup's work at the intersection of biology, chemistry and computer science.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
More News: Biology | Chemistry | Computers | Health Management | Parkinson's Disease | Pharmaceuticals | Science